WallStSmart

Heartflow, Inc. Common Stock (HTFL)vsVeeva Systems Inc Class A (VEEV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Veeva Systems Inc Class A generates 1634% more annual revenue ($3.32B vs $191.42M). VEEV leads profitability with a 28.4% profit margin vs -58.4%. VEEV earns a higher WallStSmart Score of 69/100 (B-).

HTFL

Avoid

30

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 7.0
Piotroski: 4/9Altman Z: -1.02

VEEV

Strong Buy

69

out of 100

Grade: B-

Growth: 7.3Profit: 8.0Value: 7.3Quality: 9.0
Piotroski: 4/9Altman Z: 4.78
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HTFL.

VEEVUndervalued (+38.9%)

Margin of Safety

+38.9%

Fair Value

$289.59

Current Price

$201.20

$88.39 discount

UndervaluedFair: $289.59Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HTFL2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
41.3%10/10

Revenue surging 41.3% year-over-year

Debt/EquityHealth
0.0910/10

Conservative balance sheet, low leverage

VEEV6 strengths · Avg: 9.2/10
Operating MarginProfitability
30.9%10/10

Strong operational efficiency at 30.9%

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.7810/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

PEG RatioValuation
0.888/10

Growing faster than its price suggests

Revenue GrowthGrowth
16.3%8/10

16.3% revenue growth

Areas to Watch

HTFL4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-135.3%2/10

ROE of -135.3% — below average capital efficiency

Free Cash FlowQuality
$-31.99M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
-1.022/10

Distress zone — elevated risk

VEEV1 concerns · Avg: 4.0/10
P/E RatioValuation
34.6x4/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : HTFL

The strongest argument for HTFL centers on Revenue Growth, Debt/Equity. Revenue growth of 41.3% demonstrates continued momentum.

Bull Case : VEEV

The strongest argument for VEEV centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 28.4% and operating margin at 30.9%. Revenue growth of 16.3% demonstrates continued momentum.

Bear Case : HTFL

The primary concerns for HTFL are EPS Growth, Return on Equity, Free Cash Flow.

Bear Case : VEEV

The primary concerns for VEEV are P/E Ratio.

Key Dynamics to Monitor

HTFL profiles as a hypergrowth stock while VEEV is a growth play — different risk/reward profiles.

HTFL is growing revenue faster at 41.3% — sustainability is the question.

VEEV generates stronger free cash flow (1.1B), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

VEEV scores higher overall (69/100 vs 30/100), backed by strong 28.4% margins and 16.3% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Heartflow, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases globally. The company is headquartered in Mountain View, California.

Veeva Systems Inc Class A

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.

Visit Website →

Want to dig deeper into these stocks?